Merck signs HIV prevention drug licenses covering 129 countries

July 24, 2026 6:45 AM

Merck (NYSE: MRK) has signed seven non-exclusive voluntary licensing agreements with generic manufacturers for alimatravir (MK-8527), an investigational once-monthly oral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found